Leukotriene B4 as a mediator of early and late reactions to antigen in humans: The effect of systemic glucocorticoid treatment in vivo
- 31 March 1989
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 83 (3) , 634-642
- https://doi.org/10.1016/0091-6749(89)90076-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge.Journal of Clinical Investigation, 1987
- Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.Journal of Clinical Investigation, 1987
- Inflammatory Mediators in Late Antigen-Induced RhinitisNew England Journal of Medicine, 1985
- The Mechanisms of Antiinflammatory Steriod Action in Allergic DiseasesAnnual Review of Pharmacology and Toxicology, 1985
- Allergen‐Induced Release of Sulphidopeptide Leukotrienes (SRS‐A) and LTB4 in Allergic RhinitisAllergy, 1985
- Peptide Leukotriene Release after Antigen Challenge in Patients Sensitive to RagweedNew England Journal of Medicine, 1984
- The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology.Journal of Clinical Investigation, 1984
- Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells.Journal of Clinical Investigation, 1983
- Neutrophil Chemotactic Activity in Antigen-Induced Late Asthmatic ReactionsNew England Journal of Medicine, 1982
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980